Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2026
RELIGARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.4 pts more than its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Religare Enterprises Limited reported a standalone net loss of Rs. 3,379.87 lakhs for FY26, slightly improved from Rs. 3,754.28 lakhs loss in FY25. Total standalone income declined sharply to Rs. 1,644.09 lakhs from Rs. 4,182.01 lakhs (a ~61% drop), reflecting reduced operations. On consolidated basis, the group achieved net profit of Rs. 8,888.1 lakhs for FY26 (Q4: Rs. 10,790.71 lakhs), driven primarily by subsidiary Care Health Insurance. Key developments include: ongoing governance review by external law firm investigating past practices at RFL and RHDFCL; income tax demand of Rs. 10,853 lakhs for AY 2017-18 under litigation; demerger scheme proposed for financial services business to RFL pending regulatory approvals; and settlement of Tech Mahindra dispute for Rs. 5 crores. Preference share redemptions of Rs. 8,403 lakhs remain disputed with EOW/NCLT matters pending. Un-modified audit opinions issued despite Emphasis of Matter on tax litigations and RCML not being consolidated.
While consolidated operations turned profitable mainly due to insurance subsidiary, standalone entity continues to incur losses with revenue declining significantly. Pending litigations, governance issues, and preference share disputes create uncertainty. The proposed demerger, if approved, could restructure the company's financial services business.